AstaReal AB appoints Daniel Flodqvist as new CEO
Swedish supplement company AstaReal AB appoints Daniel Flodqvist as the new Chief Executive Officer. He succeeds Peter Worsöe, who, after five years leading the Swedish company, will transition to a new role as CEO of AstaReal Inc. in North and South America.
“I am honored to take on the role of CEO at AstaReal AB. It’s a company with a strong legacy in health and nutrition, as well as R&D. Now we will continue to drive innovation and global expansion,” says Daniel Flodqvist.
Daniel Flodqvist, new CEO of AstaReal AB.
The newly appointed CEO at AstaReal, Daniel Flodqvist, has a strong background in leading growth and transformation across both B2B and B2C environments, with experience spanning Europe, the Americas, and Asia. He has previously held executive roles at, among others, eye-tracking tech company Tobii and Colgate-Palmolive.
“My ambition together with the team is to strengthen AstaReal’s position as a global leader in health solutions and natural astaxanthin. We will continue to invest in science, sustainability, and strategic partnerships to create long-term value for our customers and society,” says Daniel Flodqvist.
With the appointment of Daniel Flodqvist, Peter Worsöe steps down as AstaReal CEO in Sweden after five years.
“It has been a privilege to work with such a dedicated and talented team at AstaReal, and I’m proud of what we’ve achieved together. I am confident that Daniel’s international experience and dynamic leadership will be of great value for the company moving forward,” says Peter Worsöe.
Daniel Flodqvist started as CEO on April 24, 2025.
For more information, please contact:
Edwin Eriksson, Press Contact, +46 (0)73 975 79 19, edwin.eriksson@greatness.se
Peter Ahlm, Head of Marketing & Sales, +46 (0)73 868 48 39, peter.ahlm@astareal.se
AstaReal AB is a global leader in the production and research of natural antioxidant astaxanthin, with clinically proven solutions to enhance health and well-being. With origins in Uppsala University, Sweden, AstaReal was first to commercially produce natural astaxanthin and introduced the Astaxin supplement in 1995. The company supplies natural astaxanthin to supplement manufacturers and produces its own brand products. AstaReal is part of the AstaReal Group, fully owned by Fuji Chemical Industries Co., Ltd., with its European headquarters in Stockholm. Read more at www.astareal.se
